Immix Biopharma, Inc. Share Price

Immix Biopharma, Inc. Share Price

NASDAQ: IMMX | Micro Cap
$7.23
-$0.26 (-3.47%) Last updated on 18 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Immix Biopharma, Inc. Stock Performance

Open
$7.48
Prev. Close
$7.49
Circuit Range
N/A
Day Range
$7.14 - $7.48
Year Range
$3.79 - $15.09
Volume
35,508
Average Traded
$7.25

Immix Biopharma, Inc. Share Price Today

As of 18 November 2026, Immix Biopharma, Inc.'s share price is $7.23. The stock opened at $7.48, compared to its previous close of $7.49. During today's trading session, Immix Biopharma, Inc.'s share price traded between $7.14 and $7.48, with an average price of $7.31. Over the past 52 weeks, the stock has recorded a high of $15.09 and a low of $3.79. In terms of performance, Immix Biopharma, Inc.'s share price has declined by 19.53% over the last six months and is up 69.32% on a year-on-year basis.

Immix Biopharma, Inc. Share Price Chart

Line chart of the Immix Biopharma, Inc. price trend over the selected period. The price fell overall, ranging from 7.13 to 7.48, ending at 7.23.
$7.14$7.48
L
Show Current Price
H

Immix Biopharma, Inc. Stock Fundamentals & Key Indicators

Market Cap
$238.34M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.55
Revenue (TTM)
$0.00
Return On Equity (TTM)
-13.79%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-30.31%

Immix Biopharma, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$10.69-$10.04-$11.56-$13.93
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A6.08%-15.14%-20.50%

Immix Biopharma, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$8.23-$15.43-$21.61-$29.44
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-87.48%-40.05%-36.23%

About Immix Biopharma, Inc.

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.

Immix Biopharma, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$7.64
$7.21
-6.18%
Oct 2026
$10.09
$7.68
-26.26%
Sep 2026
$14.03
$10.41
-27.12%
Aug 2026
$8.31
$14.29
+71.65%
Jul 2026
$10.19
$8.32
-19.10%
Jun 2026
$8.93
$10.29
+14.52%
May 2026
$8.91
$8.98
+0.50%
Apr 2026
$9.43
$8.94
-2.08%
Mar 2026
$8.11
$9.13
+13.42%
Feb 2026
$5.78
$8.05
+38.44%
Jan 2026
$5.24
$5.82
+11.61%
Dec 2025
$4.22
$5.21
+22.01%

IMMX Share Price FAQs